小林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4967/E01047 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2012/09/07 | 日証協 | 122,279株 | -11.27% | 130,458株 | +72.9% | 170,268株 | -7.96% | 52,035株 | -34.55% |
2012/08/31 | 日証協 | 137,808株 | -11.47% | 75,455株 | -24.8% | 184,998株 | -2.73% | 79,502株 | +275.01% |
2012/08/24 | 日証協 | 155,658株 | -11.17% | 100,339株 | -28.3% | 190,198株 | -10.8% | 21,200株 | -48.39% |
2012/08/17 | 日証協 | 175,233株 | -2.99% | 139,952株 | +50.93% | 213,222株 | -5.83% | 41,078株 | +59.64% |
2012/08/10 | 日証協 | 180,636株 | +7.45% | 92,726株 | -64.1% | 226,422株 | -0.69% | 25,732株 | -75.52% |
2012/08/03 | 日証協 | 168,114株 | -2.43% | 258,285株 | +123.32% | 227,990株 | -4.07% | 105,101株 | -13.73% |
2012/07/27 | 日証協 | 172,294株 | -7.37% | 115,655株 | +79.87% | 237,652株 | -9.17% | 121,835株 | +170.19% |
2012/07/20 | 日証協 | 185,994株 | -1.76% | 64,300株 | -65.87% | 261,649株 | -0.7% | 45,093株 | -71.52% |
2012/07/13 | 日証協 | 189,330株 | -1.12% | 188,396株 | +173.19% | 263,488株 | +3.94% | 158,345株 | +61.78% |
2012/07/06 | 日証協 | 191,470株 | +1.4% | 68,962株 | -61% | 253,488株 | +9.73% | 97,877株 | +13.3% |
2012/06/29 | 日証協 | 188,820株 | +5.83% | 176,814株 | +48.38% | 231,001株 | -9.83% | 86,390株 | -38.05% |
2012/06/22 | 日証協 | 178,416株 | +3.06% | 119,163株 | -24.58% | 256,188株 | +9.98% | 139,453株 | +354.97% |
2012/06/15 | 日証協 | 173,124株 | -1.78% | 158,004株 | -10.76% | 232,946株 | -2.93% | 30,651株 | -43.1% |
2012/06/08 | 日証協 | 176,262株 | -6.87% | 177,054株 | +30.96% | 239,984株 | +3.47% | 53,872株 | -2.41% |
2012/06/01 | 日証協 | 189,270株 | +3.7% | 135,200株 | +34.56% | 231,942株 | +5.42% | 55,200株 | -48.57% |
2012/05/25 | 日証協 | 182,514株 | +7.54% | 100,473株 | -6.95% | 220,010株 | +9.54% | 107,337株 | +231.02% |
2012/05/18 | 日証協 | 169,717株 | +2.47% | 107,980株 | -31.41% | 200,849株 | +2.16% | 32,426株 | -21.01% |
2012/05/11 | 日証協 | 165,628株 | +1.86% | 157,438株 | +417.33% | 196,596株 | -1.68% | 41,050株 | +239.26% |
2012/05/02 | 日証協 | 162,610株 | 0% | 30,433株 | -14.2% | 199,953株 | -5.1% | 12,100株 | -34.95% |
※株式分割は考慮していませんのでご注意ください。
Page Top